The buyer question
Which decisions define the Boston asset-management mandate — institutional asset management at the documented hub scale, or alternatives — and which investment outcomes will the candidate personally own?
What the public record shows
The frame is the verified Boston biopharma record: the 2025 employment contraction with funding rebound documents the state-cycle context; asset management operates in the same institutional-financial cluster.
Cycle facts say nothing about any Boston firm's candidate pool, wages or vacancy duration.
What changes in this market
Boston mandates split by asset class. Long-only mandates prove themselves in long-term performance and flows managed. Alternatives mandates prove themselves in fund outcomes delivered. Wealth mandates prove themselves in client outcomes.
KiTalent's mandate analysis
- Name the asset class — long-only, alternatives, or wealth.
- For long-only mandates, ask for performance and flows managed.
- For alternatives mandates, ask for fund outcomes delivered.
- For wealth mandates, ask for client outcomes.
Where the public record stops
No cited source here measures candidate availability, compensation or time-to-hire. Test those points against the live mandate.
Sources
Related KiTalent research
- The Market Map Is Not the Shortlist: why market coverage and candidate assessment are separate decisions in an executive-search mandate
- How to Assess a Leader Beyond Competencies: a practical framework for testing judgment, evidence and operating context after the brief is defined
